Menopause, reproductive life, hormone replacement therapy, and bone phenotype at age 60-64 years: A british birth cohort

Journal of Clinical Endocrinology and Metabolism

Volumn 101, Issue 10, 2016, Pages 3827-3837

  Kuh, D ^a   Muthuri, S ^a   Cooper, R ^a   Moore, A ^a   MacKinnon, K ^a   Cooper, C ^b   Adams, J E ^c   Hardy, R ^a   Ward, K A ^b,d  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AREAL BONE MINERAL DENSITY; ARTICLE; BONE; BONE DENSITOMETER; BONE DENSITY; BONE MASS; BONE STRENGTH; CHILD; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORTICAL BONE; DISTAL RADIUS; DUAL ENERGY X RAY ABSORPTIOMETRY; ENGLAND; FEMALE; FOLLOW UP; HIP; HORMONE SUBSTITUTION; HUMAN; LUMBAR SPINE; MENARCHE; MENOPAUSE; MIDDLE AGED; MUSCULOSKELETAL DISEASE ASSESSMENT; POLAR STRENGTH STRAIN INDEX; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIAL SHAFT; REPRODUCTIVE BEHAVIOR; SCHOOL CHILD; SCOTLAND; TRABECULAR BONE; VOLUMETRIC BONE MINERAL DENSITY; WALES; X RAY BONE DENSITOMETER; AGE; DIAGNOSTIC IMAGING; EPIDEMIOLOGY; LONGITUDINAL STUDY; PHENOTYPE; PHOTON ABSORPTIOMETRY; PHYSIOLOGY; STATISTICS AND NUMERICAL DATA; TIME FACTOR;

ABSORPTIOMETRY, PHOTON; AGE FACTORS; BONE AND BONES; BONE DENSITY; ENGLAND; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; LONGITUDINAL STUDIES; MENARCHE; MENOPAUSE; MIDDLE AGED; PHENOTYPE; SCOTLAND; TIME FACTORS; WALES;

EID: 84991629008     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2016-1828     Document Type: Article

References (46)

1. Abrahamsen B, van ST, Ariely R, Olson M, Cooper C. Excess mortality following hip fracture: a systematic epidemiological review. Osteoporos Int. 2009;20(10):1633-1650.
2. Kritz-Silverstein D, Barrett-Connor E. Early menopause, number of reproductive years, and bone mineral density in postmenopausal women. Am J Public Health. 1993;83(7):983-988.
3. Johnell O, Gullberg B, Kanis JA, et al. Risk factors for hip fracture in European women: the MEDOS Study. Mediterranean Osteoporosis Study. J Bone Miner Res. 1995;10(11):1802-1815.
4. Osei-Hyiaman D, Satoshi T, Ueji M, Hideto T, Kano K. Timing of menopause, reproductive years, and bone mineral density: a cross-sectional study of postmenopausal Japanese women. Am J Epidemiol. 1998;148(11):1055-1061.
5. Banks E, Reeves GK, Beral V, Balkwill A, Liu B, Roddam A. Hip fracture incidence in relation to age, menopausal status, and age at menopause: prospective analysis. PLoS Med. 2009;6(11):e1000181.
6. Sullivan SD, Lehman A, Thomas F, et al. Effects of self-reported age at nonsurgical menopause on time to first fracture and bone mineral density in the Women's Health Initiative Observational Study. Menopause. 2015;22(10):1035-1044.
7. Gerdhem P, Obrant KJ. Bone mineral density in old age: the influ-enceofageatmenarche andmenopause. J Bone Miner Metab.2004; 22(4):372-375.
8. Sioka C, Fotopoulos A, Georgiou A, Xourgia X, Papadopoulos A, Kalef-Ezra JA. Age at menarche, age at menopause and duration of fertility as risk factors for osteoporosis. Climacteric. 2010;13(1): 63-71.
9. Kritz-Silverstein D, von Muhlen DG, Barrett-Connor E. Hysterectomy and oophorectomy are unrelated to bone loss in older women. Maturitas. 2004;47(1):61-69.
10. Antoniucci DM, Sellmeyer DE, Cauley JA, et al. Postmenopausal bilateral oophorectomyisnot associated with increased fracture risk in older women. J Bone Miner Res. 2005;20(5):741-747.
11. Melton LJ, III, Achenbach SJ, Gebhart JB, Babalola EO, Atkinson EJ, Bharucha AE. Influence of hysterectomy on long-term fracture risk. Fertil Steril. 2007;88(1):156-162.
12. Vesco KK, Marshall LM, Nelson HD, et al. Surgical menopause and nonvertebral fracture risk among older US women. Menopause. 2012;19(5):510-516.
13. Cauley JA, Robbins J, Chen Z, et al. Effects of estrogen plus pro-gestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial. JAMA. 2003;290(13):1729-1738.
14. Anderson GL, Limacher M, Assaf AR, et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA. 2004;291(14):1701-1712.
15. Barrett-Connor E, Wehren LE, Siris ES, et al. Recency and duration of postmenopausal hormone therapy: effects on bone mineral density and fracture risk in the National Osteoporosis Risk Assessment (NORA) study. Menopause. 2003;10(5):412-419.
16. Banks E, Beral V, Reeves G, Balkwill A, Barnes I. Fracture incidence in relation to the pattern of use of hormone therapy in postmeno-pausal women. JAMA. 2004;291(18):2212-2220.
17. Karim R, Dell RM, Greene DF, Mack WJ, Gallagher JC, Hodis HN. Hip fracture in postmenopausal women after cessation of hormone therapy: results from a prospective study in a large health management organization. Menopause. 2011;18(11):1172-1177.
18. Mikkola TM, Heinonen A, Kovanen V, et al. Influence of long-term postmenopausal hormone-replacement therapy on estimated structural bone strength:astudyindiscordant monozygotic twins.J Bone Miner Res. 2011;26(3):546-552.
19. Mishra G, Hardy R, Kuh D. Are the effects of risk factors for timing of menopause modified by age? Results from a British birth cohort study. Menopause. 2007;14(4):717-724.
20. Hardy R, Mishra GD, Kuh D. Body mass index trajectories and age at menopause in a British birth cohort. Maturitas. 2008;59(4):304-314.
21. Mishra GD, Kuh D. Health symptoms during midlife in relation to menopausal transition: British prospective cohort study. BMJ. 2012;344:e402.
22. Muller ME, Webber CE, Adachi JD. Hormone replacement therapy improves distal radius bone structure by endocortical mineral deposition. Can J Physiol Pharmacol. 2003;81(10):952-958.
23. Kuh D, Pierce M, Adams J, et al. Cohort profile: updating the cohort profile for the MRC National Survey of Health and Development: a new clinic-based data collection for ageing research. Int J Epidemiol. 2011;40(1):e1-e9.
24. Stafford M, Black S, Shah I, et al. Using a birth cohort to study ageing: representativeness and response rates in the National Survey of Health and Development. Eur J Ageing. 2013;10(2):145-157.
25. Kuh D, Wills AK, Shah I, et al. Growth from birth toadulthood and bone phenotype in early old age: a British birth cohort study. J Bone Miner Res. 2014;29(1):123-133.
26. Ferretti JL, Capozza RF, Zanchetta JR. Mechanical validation of a tomographic (pQCT) index for noninvasive estimation of rat femur bending strength. Bone. 1996;18(2):97-102.
27. e scale simplify the presentation of log transformed data. Stat Med. 2000;19:3109-3125.
28. Akhter MP, Lappe JM, Davies KM, Recker RR. Transmenopausal changes in the trabecular bone structure. Bone. 2007;41(1):111-116.
29. Riggs BL, Melton LJ III, Robb RA, et al. Population-based study of age and sex differences in bone volumetric density, size, geometry, and structure at different skeletal sites. J Bone Miner Res. 2004; 19(12):1945-1954.
30. Hagemans ML, van der Schouw YT, de Kleijn MJ, et al. Indicators for the total duration of premenopausal endogenous estrogen exposure in relation to BMD. Hum Reprod. 2004;19(9):2163-2169.
31. Sowers MR, Zheng H, Greendale GA, et al. Changes in bone re-sorption across the menopause transition: effects of reproductive hormones, body size, and ethnicity. J Clin Endocrinol Metab. 2013; 98(7):2854-2863.
32. Brincat SD, Borg M, Camilleri G, Calleja-Agius J. The role of cy-tokines in postmenopausal osteoporosis. Minerva Ginecol. 2014; 66(4):391-407.
33. Kosa JP, Balla B, Speer G, et al. Effect of menopause on gene expression pattern in bone tissue of nonosteoporotic women. Menopause. 2009;16(2):367-377.
34. Maltais ML, Desroches J, Dionne IJ. Changes in muscle mass and strength after menopause.J Musculoskelet Neuronal Interact. 2009; 9(4):186-197.
35. Komulainen M, Kroger H, Tuppurainen MT, et al. Prevention of femoral and lumbar bone loss with hormone replacement therapy and vitamin D3 in early postmenopausal women: a population-based 5-year randomized trial. J Clin Endocrinol Metab. 1999; 84(2):546-552.
36. Cauley JA, Black DM, Barrett-Connor E, et al. Effects of hormone replacement therapy on clinical fractures and height loss: the Heart and Estrogen/Progestin Replacement Study (HERS). Am J Med. 2001;110(6):442-450.
37. Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin forsecondarypreventionofcoronaryheartdiseaseinpost-menopausal women. JAMA. 1998;280:605-613.
38. Wells G, Tugwell P, Shea B, et al. Meta-analyses of therapies for postmenopausal osteoporosis. V. Meta-analysis of the efficacy of hormone replacement therapy in treating and preventing osteoporosis in postmenopausal women. Endocr Rev. 2002;23(4):529-539.
39. Jackson RD, Wactawski-Wende J, LaCroix AZ, et al. Effects of conjugated equine estrogen on risk of fractures and BMD in post-menopausal women with hysterectomy: results from the Women's Health Initiative randomized trial. J Bone Miner Res. 2006;21(6): 817-828.
40. Uusi-Rasi K, Beck TJ, Sievanen H, Heinonen A, Vuori I. Associa-tionsofhormone replacementtherapywith bone structureand physical performance among postmenopausal women. Bone. 2003;32: 704-710.
41. Oliver H, Jameson KA, Sayer AA, Cooper C, Dennison EM. Growth in early life predicts bone strength in late adulthood: the Hertfordshire Cohort Study. Bone. 2007;41(3):400-405.
42. Cooper R, Hardy R, Kuh D. Is adiposity across life associated with subsequent hysterectomy risk? Findings from the 1946 British birth cohort study. BJOG. 2008;115(2):184-192.
43. Cooper R, Hardy R, Kuh D. Timing of menarche, childbearing and hysterectomy risk. Maturitas. 2008;61(4):317-322.
44. Kuh D, Hardy R, Wadsworth M. Social and behavioural influences on the uptake of hormone replacement therapy among younger women. Br J Obstet Gynaecol. 2000;107:731-739.
45. Cole TJ, Kuh D, Johnson W, et al. Using SITAR to relate pubertal growth to bone health in later life: the MRC National Survey of Health and Development. Int J Epidemiol. In press.
46. Mishra G, Kok H, Ecob R, Cooper R, Hardy R, Kuh D. Cessation of hormone replacement therapy after reports of adverse findings from randomized controlled trials: evidence from a British Birth Cohort. Am J Public Health. 2006;96(7):1219-1225.